HKSE:01530 (China)
Â
Shs Unitary 144A/Reg S
HK$
6.74
(-0.15%)
May 10
Business Description
3SBio Inc
NAICS : 325412
SIC : 2834
ISIN : KYG8875G1029
Share Class Description:
HKSE:01530: Shs Unitary 144A/Reg SCompare
Compare
Traded in other countries / regions
01530.Hong Kong83B.GermanyTRSBF.USA IPO Date
2015-06-11Description
3SBio Inc, or 3SBio is a biotechnology company. As a pioneer in the Chinese biotechnology industry, the Group has extensive expertise in researching, developing, manufacturing, and marketing biopharmaceuticals. The core products of the Group include several biopharmaceutical drugs, TPIAO recombinant human erythropoietin rhEPO products EPIAO and SEPO, Yisaipu, Cipterbin, and a small molecule drug, Mandi. Except for minoxidil, an over-the-counter drug, the others are all older-generation biologics. The majority of its pipeline candidates are "me-too" drugs and in general, are still at an early stage.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.24 | |||||
| Equity-to-Asset | 0.59 | |||||
| Debt-to-Equity | 0.35 | |||||
| Debt-to-EBITDA | 1.92 | |||||
| Interest Coverage | 11.58 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 2.71 | |||||
| Beneish M-Score | -2.35 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 13.3 | |||||
| 3-Year EBITDA Growth Rate | 22.7 | |||||
| 3-Year EPS without NRI Growth Rate | 19.8 | |||||
| 3-Year FCF Growth Rate | 58.2 | |||||
| 3-Year Book Growth Rate | 8.7 | |||||
| Future 3-5Y Total Revenue Growth Rate | 8.7 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 76.58 | |||||
| 9-Day RSI | 73.22 | |||||
| 14-Day RSI | 68.97 | |||||
| 6-1 Month Momentum % | -13.84 | |||||
| 12-1 Month Momentum % | -21.76 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.47 | |||||
| Quick Ratio | 2.26 | |||||
| Cash Ratio | 1.61 | |||||
| Days Inventory | 232.63 | |||||
| Days Sales Outstanding | 54.69 | |||||
| Days Payable | 76.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.48 | |||||
| Dividend Payout Ratio | 0.13 | |||||
| Forward Dividend Yield % | 3.71 | |||||
| 5-Year Yield-on-Cost % | 1.48 | |||||
| 3-Year Average Share Buyback Ratio | 1.9 | |||||
| Shareholder Yield % | -2.17 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 84.98 | |||||
| Operating Margin % | 31.45 | |||||
| Net Margin % | 19.82 | |||||
| FCF Margin % | 17.64 | |||||
| ROE % | 11.41 | |||||
| ROA % | 6.71 | |||||
| ROIC % | 12.36 | |||||
| ROC (Joel Greenblatt) % | 40 | |||||
| ROCE % | 10.94 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 9.93 | |||||
| PE Ratio without NRI | 8.58 | |||||
| Shiller PE Ratio | 13.32 | |||||
| Price-to-Owner-Earnings | 12.3 | |||||
| PEG Ratio | 0.8 | |||||
| PS Ratio | 1.92 | |||||
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.78 | |||||
| Price-to-Free-Cash-Flow | 10.92 | |||||
| Price-to-Operating-Cash-Flow | 7.22 | |||||
| EV-to-EBIT | 6.23 | |||||
| EV-to-Forward-EBIT | 5.7 | |||||
| EV-to-EBITDA | 5.4 | |||||
| EV-to-Forward-EBITDA | 4.88 | |||||
| EV-to-Revenue | 1.75 | |||||
| EV-to-Forward-Revenue | 1.5 | |||||
| EV-to-FCF | 9.89 | |||||
| Price-to-Projected-FCF | 0.61 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.8 | |||||
| Price-to-Graham-Number | 0.82 | |||||
| Earnings Yield (Greenblatt) % | 16.05 | |||||
| FCF Yield % | 9.33 | |||||
| Forward Rate of Return (Yacktman) % | 16.58 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
3SBio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 8,548.914 | ||
| EPS (TTM) (HK$) | 0.679 | ||
| Beta | 1.08 | ||
| Volatility % | 35.03 | ||
| 14-Day RSI | 68.97 | ||
| 14-Day ATR (HK$) | 0.254187 | ||
| 20-Day SMA (HK$) | 6.1335 | ||
| 12-1 Month Momentum % | -21.76 | ||
| 52-Week Range (HK$) | 4.91 - 8.09 | ||
| Shares Outstanding (Mil) | 2,398.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
3SBio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
3SBio Inc Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
3SBio Inc Frequently Asked Questions
What is 3SBio Inc(HKSE:01530)'s stock price today?
The current price of HKSE:01530 is HK$6.74. The 52 week high of HKSE:01530 is HK$8.09 and 52 week low is HK$4.91.
When is next earnings date of 3SBio Inc(HKSE:01530)?
The next earnings date of 3SBio Inc(HKSE:01530) is 2024-08-23 Est..
Does 3SBio Inc(HKSE:01530) pay dividends? If so, how much?
The Dividend Yield %  of 3SBio Inc(HKSE:01530) is 1.48% (As of Today), Highest Dividend Payout Ratio of 3SBio Inc(HKSE:01530) was 0.23. The lowest was 0.13. And the median was 0.13. The  Forward Dividend Yield % of 3SBio Inc(HKSE:01530) is 3.71%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers